Search Results - Peer Brehm Christensen
- Showing 1 - 17 results of 17
-
1
-
2
Immunological Characteristics of Patients Receiving Ultra-Short Treatment for Chronic Hepatitis C by Lone Wulff Madsen, Lone Wulff Madsen, Peer Brehm Christensen, Peer Brehm Christensen, Anne Øvrehus, Anne Øvrehus, Dorthe Marie Sjødahl Bryde, Dorte Kinggaard Holm, Dorte Kinggaard Holm, Søren Thue Lillevang, Søren Thue Lillevang, Christian Nielsen, Christian Nielsen
Published 2022-06-01
Article -
3
-
4
Combining liver stiffness with hyaluronic acid provides superior prognostic performance in chronic hepatitis C. by Janne Fuglsang Hansen, Karen Mølgaard Christiansen, Benjamin Staugaard, Belinda Klemmensen Moessner, Søren Lillevang, Aleksander Krag, Peer Brehm Christensen
Published 2019-01-01
Article -
5
Mortality among patients with cleared hepatitis C virus infection compared to the general population: a Danish nationwide cohort study. by Lars Haukali Omland, Peer Brehm Christensen, Henrik Krarup, Peter Jepsen, Nina Weis, Henrik Toft Sørensen, Niels Obel, DANVIR Cohort Study
Published 2011-01-01
Article -
6
Effect of direct-acting antivirals on the titers of human pegivirus 1 during treatment of chronic hepatitis C patients by Ulrik Fahnøe, Lone Wulff Madsen, Peer Brehm Christensen, Christina Søhoel Sølund, Sarah Mollerup, Mette Pinholt, Nina Weis, Anne Øvrehus, Jens Bukh
Published 2024-09-01
Article -
7
Microfibrillar-Associated Protein 4: A Potential Biomarker for Screening for Liver Fibrosis in a Mixed Patient Cohort. by Susanne Gjørup Sækmose, Belinda Mössner, Peer Brehm Christensen, Kristoffer Lindvig, Anders Schlosser, René Holst, Torben Barington, Uffe Holmskov, Grith Lykke Sorensen
Published 2015-01-01
Article -
8
Neutralizing antibodies in patients with chronic hepatitis C, genotype 1, against a panel of genotype 1 culture viruses: lack of correlation to treatment outcome. by Jannie Pedersen, Tanja B Jensen, Thomas H R Carlsen, Kristian Schønning, Peer Brehm Christensen, Alex Lund Laursen, Henrik Krarup, Jens Bukh, Nina Weis
Published 2013-01-01
Article -
9
-
10
A multi-level intervention to eliminate hepatitis C from the Region of Southern Denmark: the C-Free-South project by Sandra Dröse, Anne Lindebo Holm Øvrehus, Dorte Kinggaard Holm, Lone Wulff Madsen, Belinda Klemmensen Mössner, Jacob Søholm, Janne Fuglsang Hansen, Birgit Thorup Røge, Peer Brehm Christensen
Published 2022-03-01
Article -
11
A novel fibrosis index comprising a non-cholesterol sterol accurately predicts HCV-related liver cirrhosis. by Magdalena Ydreborg, Vera Lisovskaja, Martin Lagging, Peer Brehm Christensen, Nina Langeland, Mads Rauning Buhl, Court Pedersen, Kristine Mørch, Rune Wejstål, Gunnar Norkrans, Magnus Lindh, Martti Färkkilä, Johan Westin
Published 2014-01-01
Article -
12
Impact of IL28B-related single nucleotide polymorphisms on liver histopathology in chronic hepatitis C genotype 2 and 3. by Karolina Rembeck, Asa Alsiö, Peer Brehm Christensen, Martti Färkkilä, Nina Langeland, Mads Rauning Buhl, Court Pedersen, Kristine Mørch, Johan Westin, Magnus Lindh, Kristoffer Hellstrand, Gunnar Norkrans, Martin Lagging
Published 2012-01-01
Article -
13
Hepatitis C prevalence in Denmark in 2016-An updated estimate using multiple national registers. by Stine Nielsen, Janne Fuglsang Hansen, Gordon Hay, Susan Cowan, Peter Jepsen, Lars Haukali Omland, Henrik Bygum Krarup, Jacob Søholm, Jeffrey V Lazarus, Nina Weis, Anne Øvrehus, Peer Brehm Christensen
Published 2020-01-01
Article -
14
Genetic Variants in the Apoptosis Gene BCL2L1 Improve Response to Interferon-Based Treatment of Hepatitis C Virus Genotype 3 Infection by Louise Nygaard Clausen, Nina Weis, Steen Ladelund, Lone Madsen, Suzanne Lunding, Britta Tarp, Peer Brehm Christensen, Henrik Bygum Krarup, Axel Møller, Jan Gerstoft, Mette Rye Clausen, Thomas Benfield, the DANHEP group
Published 2015-02-01
Article -
15
Low incidence of HCC in chronic hepatitis C patients with pretreatment liver stiffness measurements below 17.5 kilopascal who achieve SVR following DAAs. by Jacob Søholm, Janne Fuglsang Hansen, Belinda Mössner, Birgit Thorup Røge, Alex Lauersen, Jesper Bach Hansen, Nina Weis, Toke Seierøe Barfod, Suzanne Lunding, Anne Øvrehus, Rajesh Mohey, Peter Thielsen, Peer Brehm Christensen
Published 2020-01-01
Article -
16
Impact of obesity on the bioavailability of peginterferon-α2a and ribavirin and treatment outcome for chronic hepatitis C genotype 2 or 3. by Åsa Alsiö, Karolina Rembeck, Galia Askarieh, Peer Brehm Christensen, Martti Färkkilä, Nina Langeland, Mads Rauning Buhl, Court Pedersen, Kristine Mørch, Bart L Haagmans, Salmir Nasic, Johan Westin, Kristoffer Hellstrand, Gunnar Norkrans, Martin Lagging
Published 2012-01-01
Article -
17
The Mortality After Release from Incarceration Consortium (MARIC): Protocol for a multi-national, individual participant data meta-analysis by Rohan Borschmann, Holly Tibble, Matthew J Spittal, David Preen, Jane Pirkis, Sarah Larney, David L Rosen, Jesse T Young, Alexander D Love, Frederick L Altice, Ingrid A Binswanger, Anne Bukten, Tony Butler, Zheng Chang, Chuan-Yu Chen, Thomas Clausen, Peer Brehm Christensen, Gabriel J Culbert, Louisa Degenhardt, Anja J.E. Dirkzwager, Kate Dolan, Seena Fazel, Colin Fischbacher, Margaret Giles, Lesley Graham, David Harding, Yen-Fang Huang, Florence Huber, Azar Karaminia, Fiona G Kouyoumdjian, Sungwoo Lim, Lars Møller, Akm Moniruzzaman, Jeffrey Morenoff, Eamonn O'Moore, Lia N Pizzicato, Daniel Pratt, Scott F Proescholdbell, Shabbar I Ranapurwala, Meghan E Shanahan, Jenny Shaw, Julian M Somers, Anne C Spaulding, Marc F Stern, Kendra M Viner, Nadia Wang, Melissa Willoughby, Stuart A Kinner
Published 2020-02-01
Article